Casgevy’s approval changed the sickle cell disease landscape. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, the therapy showed that the disease could be tackled at its genetic root, ...
Scientists, biochemists, and R&D leaders in pharma and biotech seeking to harness AI to drive innovation, improve efficiency, and stay ahead in drug development. He is the author of two books and 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results